Hantavirus, particularly the New World strains that cause hantavirus cardiopulmonary syndrome (HCPS), presents a significant health threat due to its high mortality rate, which can reach 50%. Unlike typical respiratory viruses, hantavirus is primarily transmitted through contact with infected rodents, making its potential for a global pandemic currently low. However, the recent outbreak on the MV Hondius expedition ship in April and May 2026 has reignited fears about the pathogen's spread, especially in confined environments. The World Health Organization (WHO) assesses the global risk as low, but the situation underscores the importance of international health surveillance and data sharing, particularly following the United States' withdrawal from the WHO in early 2025. In a worst-case scenario, a mutation allowing airborne transmission of a high-mortality strain could lead to a catastrophic global death toll. Currently, there is no licensed vaccine or specific treatment for hantavirus; supportive care is the only defense against severe cases, which could overwhelm healthcare systems rapidly.